These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27908309)

  • 1. An unrecognised presentation of Takayasu arteritis: superficial femoral artery involvement.
    Dong H; Che W; Jiang X; Peng M; Zou Y; Zhang H; Xu B; Yang Y; Gao R
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):83-87. PubMed ID: 27908309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrograde Popliteal Access and Balloon Dilatation of Chronic Total Occlusion of Superficial Femoral Arteries.
    Kuserli Y; Kavala AA
    Ann Vasc Surg; 2020 Apr; 64():253-262. PubMed ID: 31634601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.
    Fujihara M; Takahara M; Sasaki S; Nanto K; Utsunomiya M; Iida O; Yokoi Y
    J Endovasc Ther; 2017 Jun; 24(3):367-375. PubMed ID: 28351208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M; Schmidt A; Scheinert S; Banning-Eichenseer U; Ulrich M; Bausback Y; Steiner S; Scheinert D
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Distal Hemodynamic Changes of Lower Extremity after Endovascular Treatment: Correlation between Measurements of Color-Coded Quantitative Digital Subtraction Angiography and Ankle-Brachial Index.
    Lou WS; Su HB; Huang KY; He X; Chen L; Chen GP; Shi WY; Han JF; Gu JP
    J Vasc Interv Radiol; 2016 Jun; 27(6):852-8. PubMed ID: 27106733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of using IVUS during percutaneous superficial femoral artery interventions.
    Hitchner E; Zayed M; Varu V; Lee G; Aalami O; Zhou W
    Ann Vasc Surg; 2015 Jan; 29(1):28-33. PubMed ID: 25194552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular Treatment of Iliac Artery Stenosis Caused by Takayasu Arteritis: A 10-Year Experience.
    Dong H; Chen Y; Xiong HL; Che WQ; Zou YB; Jiang XJ
    J Endovasc Ther; 2019 Dec; 26(6):810-815. PubMed ID: 31496339
    [No Abstract]   [Full Text] [Related]  

  • 12. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
    Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
    J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery.
    Baril DT; Rhee RY; Kim J; Makaroun MS; Chaer RA; Marone LK
    J Vasc Surg; 2009 Jan; 49(1):133-8; discussion 139. PubMed ID: 19174252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting-balloon angioplasty versus balloon angioplasty as treatment for short atherosclerotic lesions in the superficial femoral artery: randomized controlled trial.
    Poncyljusz W; Falkowski A; Safranow K; Rać M; Zawierucha D
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1500-1507. PubMed ID: 23576210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
    Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
    J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duplex criteria for in-stent restenosis in the superficial femoral artery.
    Kawarada O; Higashimori A; Noguchi M; Waratani N; Yoshida M; Fujihara M; Yokoi Y; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):E199-205. PubMed ID: 22639187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.
    Piorkowski M; Freitas B; Steiner S; Botsios S; Bausback Y; Scheinert D; Schmidt A
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):89-95. PubMed ID: 25410147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Evaluation of Flow-Limiting Stenoses of the Superficial Femoral and Popliteal Artery by Parametric Color-Coding Analysis of Digital Subtraction Angiography Series.
    Kostrzewa M; Kara K; Pilz L; Mueller-Muertz H; Rathmann N; Schoenberg SO; Diehl SJ
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1147-1154. PubMed ID: 28488106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.